MARINUS PHARMACEUTICALS, INC. Annual Return On Equity in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Marinus Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2015 to 2023.
  • Marinus Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2024 was -7.94K %, a 24292% decline year-over-year.
  • Marinus Pharmaceuticals, Inc. annual Return On Equity for 2023 was -265 %, a 712% decline from 2022.
  • Marinus Pharmaceuticals, Inc. annual Return On Equity for 2022 was -32.6 %, a 71.8% increase from 2021.
  • Marinus Pharmaceuticals, Inc. annual Return On Equity for 2021 was -115 %, a 57.7% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -265 -232 -712% Jan 1, 2023 Dec 31, 2023
2022 -32.6 +82.8 +71.8% Jan 1, 2022 Dec 31, 2022
2021 -115 -42.2 -57.7% Jan 1, 2021 Dec 31, 2021
2020 -73.2 +36.2 +33.1% Jan 1, 2020 Dec 31, 2020
2019 -109 -36.5 -50.1% Jan 1, 2019 Dec 31, 2019
2018 -72.9 -24.3 -50.1% Jan 1, 2018 Dec 31, 2018
2017 -48.6 +46.1 +48.7% Jan 1, 2017 Dec 31, 2017
2016 -94.6 -22.2 -30.6% Jan 1, 2016 Dec 31, 2016
2015 -72.5 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.